Oaktree Capital Management »

Cogent Biosciences shares owned by Oaktree Capital Management

Quarter-by-quarter ownership of Cogent Biosciences shares owned by Oaktree Capital Management from 13F filings

Historical chart of Oaktree Capital Management investment in Cogent Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Cogent Biosciences held by Oaktree Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cogent Biosciences by Oaktree Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $9.0M 7.7M 1.18

More positions owned by Oaktree Capital Management

Expand Energy Corp Common Stock (EXE)
Torm Common Stock (TRMD)
Anglogold Ashanti Common Stock (AU)
Vaneck Semiconductor Etf Etf Put Option (SMH)
Garrett Motion Common Stock (GTX)
State Street Corp Etf Put Option (SPY)
Indivior Pharmaceuticals Common Stock
Viper Energy Common Stock (VNOM)
Talen Energy Corp Common Stock (TLN)
Telephone And Data Systems Common Stock (TDS)
Core Scientific Common Stock (CORZ)
Barrick Mining Corp Common Stock (B)
Nokia Oyj Common Stock (NOK)
Ftai Aviation Common Stock (FTAI)
Itau Unibanco Holding Sa Common Stock (ITUB)

View all positions for Oaktree Capital Management

Top funds holding Cogent Biosciences

Linden Advisors
Ing Investment Management
D. E. Shaw & Co
Wolverine Asset Management
Sona Asset Management
Calamos Advisors
Lord, Abbett & Co
Jump Financial
Oaktree Capital Management
Polar Securities
Ameriprise Financial
Readystate Asset Management
Polar Capital Holdings
Balyasny Asset Management
SSI Investment Management

View all funds holding Cogent Biosciences